查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2106613

伴侶動物診斷市場預測（2034 年）－全球分析（按動物種類、產品類型、技術、適應症、檢體類型、檢測施行地點、最終用戶、應用、分銷管道和地區分類）

Companion Animal Diagnostics Market Forecasts to 2034 - Global Analysis By Animal Type, Product, Technology, Indication, Sample Type, Testing Location, End User, Application, Distribution Channel, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

全球伴侶動物診斷市場預計到 2026 年將達到 30 億美元，並在預測期內以 9.9% 的複合年成長率成長，到 2034 年將達到 64 億美元。

伴侶動物診斷市場涵蓋用於檢測、診斷和監測犬、貓、馬、鳥類、兔子及其他伴侶動物疾病和健康狀況的產品和服務。該市場包括血液學設備、臨床化學分析儀、免疫診斷設備、分子診斷設備、尿液檢查分析設備、血氣和電解質分析儀、血液凝固檢驗以及微生物檢測系統等診斷設備，以及耗材、試劑、試劑盒、軟體和診斷服務。寵物數量的增加、對先進獸醫護理需求的成長、伴侶動物慢性病患病率的上升以及診斷技術的進步是推動各地區市場擴張的主要因素。

寵物數量不斷增加，對先進獸醫護理的需求日益成長。

全球寵物數量的不斷成長以及對先進獸醫護理需求的日益成長是伴侶動物診斷市場的主要促進因素。寵物飼主越來越將寵物視為家庭成員，並更願意投資與人類醫學相當的先進診斷程序。寵物「人性化」的趨勢提高了人們對精準診斷、疾病監測和預防性護理的期望。隨著獸醫醫院服務範圍的擴大和獲得專業護理的便利性提高，診斷測試的使用也在增加。人們對透過診斷測試早期發現疾病益處的認知不斷提高，進一步推動了市場成長。這些已開發市場和新興市場的趨勢都支撐著對伴侶動物診斷解決方案的強勁需求。

診斷設備高成本，而獸醫院預算有限

診斷設備所需的大量資金投入，加上獸醫診所預算有限，對市場構成了重大限制。先進的診斷設備，例如血液檢測儀、分子診斷系統和免疫診斷平台，都需要大量的初步投資。規模小規模的獸醫診所可能沒有足夠的資金來購買這些設備。此外，耗材、試劑、維護和服務等持續成本也增加了設備的擁有成本。在許多地區，獸醫診斷的保險報銷限制影響了獸醫診所的財務狀況。這些成本障礙會限制設備的普及，尤其對於小規模的獸醫診所和獸醫預算有限的發展中地區而言更是如此。

即時診斷技術的進步

即時診斷技術的持續創新為伴侶動物診斷市場的擴張帶來了巨大機會。攜帶式和手持式診斷設備能夠實現快速現場檢測，從而改善臨床決策和患者預後。分子診斷技術的進步，包括聚合酶鍊式反應（PCR）和等溫擴增，使得在診療現場檢測感染疾病成為可能。免疫檢測技術也日趨普及，也較容易實際應用。互聯的數位診斷平台支援遠距會診和數據共用。隨著即時診斷技術價格的降低和普及，診斷檢測將惠及更多醫療機構，擴大市場佔有率，最終提升患者照護。

獸醫專家短缺以及操作設備所需的訓練要求。

獸醫專家數量有限以及操作診斷設備的訓練要求對市場構成重大威脅。正確操作先進的診斷設備和解讀結果需要專門的培訓，但並非所有診所都能提供此類培訓。對員工進行設備操作、維護和品管方面的培訓會增加營運成本。獸醫醫院可能難以招募到能夠操作診斷系統和解讀結果的合格人員。專家的短缺限制了先進診斷測試的普及，尤其是在服務不足的地區。這些人力資源方面的挑戰可能會延緩設備的採用和測試的使用，尤其是在先進診斷方法方面。

新型冠狀病毒（COVID-19）的影響：

新冠疫情對伴侶動物診斷市場產生了重大影響。初期，疫情封鎖期間獸醫診所就診量下降、供應鏈中斷、診所關閉等問題導致市場受到衝擊。然而，疫情期間寵物數量激增，新增了大量患者。遠端醫療和遠距會診服務迅速發展，對共用診斷數據的需求也隨之成長。獸醫診所積極應對，加強了感染控制措施，並實施了非接觸式工作流程。疫情也使人們更加關注預防醫學和疾病早期檢測。疫情過後，由於寵物飼養量的增加和人們對寵物健康的持續關注，診斷檢測的需求仍然強勁，獸醫診所也持續增加對診斷能力的投入。

在預測期內，「狗」類產品預計將佔據最大的市場佔有率。

預計在預測期內，「犬類」細分市場將佔據最大的市場佔有率，這主要得益於犬隻數量龐大且持續成長、就診頻率高以及診斷測試的廣泛應用。犬類是全球最常見的伴侶動物，在大多數地區，其飼養率超過其他寵物。犬飼主在獸醫和預防保健服務方面的支出很高。該細分市場受益於涵蓋各種疾病類別的廣泛診斷方案和成熟的檢測項目。人們對犬類健康問題的日益關注、預防保健的擴展以及慢性病盛行率的上升，都在推動檢測需求的成長。由於犬類患者數量最多且檢測使用率最高，因此犬類保持最大的市場佔有率。

預計在預測期內，分子診斷領域將呈現最高的複合年成長率。

在預測期內，分子診斷領域預計將呈現最高的成長率，這主要得益於獸醫實踐中PCR和其他分子檢測技術的日益普及、感染疾病檢測需求的成長以及使分子診斷更易於獲取的技術進步。分子診斷能夠在基因層面上檢測病原體，從而在感染疾病診斷中提供高靈敏度和特異性。該領域受益於獸醫傳染病檢查的擴展，包括呼吸道疾病、消化道疾病和媒介傳播疾病。即時檢測（PoC）分子診斷系統正在改善檢測的可近性。隨著分子檢測在獸醫實踐中日益常規化，該領域正經歷市場中最快的成長。

市佔率最大的地區：

在整個預測期內，北美預計將保持最大的市場佔有率，這主要得益於其較高的寵物擁有率、大量的獸醫護理支出以及先進的獸醫基礎設施。美國透過對獸醫實踐和診斷能力的大量投資，推動了區域市場的成長。寵物飼主對先進診斷方案的高度認知，支持了偵測需求。完善的獸醫專家網路和轉診系統確保了診斷數量的穩定性。診斷設備製造商的強大實力和技術創新推動了相關技術的普及。高額的寵物支出和完善的獸醫基礎設施使北美得以保持其市場主導地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於寵物擁有量的成長、可支配收入的增加以及中國、印度、澳大利亞和東南亞等國家對先進獸醫診斷技術的認知度不斷提高。該地區寵物擁有量的快速成長和中產階級的壯大，正在創造對獸醫診斷服務的巨大需求。獸醫實踐的現代化和新技術的應用正在加速。對獸醫教育和專業培訓投入的增加，正在擴大人才儲備。人們對診斷益處的認知不斷提高，以及保險覆蓋範圍的擴大，都在推動市場擴張。隨著獸醫學的進步，亞太地區正經歷著全球伴侶動物診斷市場最快的成長。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球伴侶動物診斷市場：依動物類型分類

  • 狗
  • 貓
  • 馬
  • 鳥
  • 兔子
  • 其他伴侶動物

第6章：全球伴侶動物診斷市場：依產品分類

  • 裝置
    • 血液分析儀
    • 臨床化學分析儀
    • 免疫診斷分析儀
    • 分子診斷設備
    • 尿液檢查儀
    • 血液氣體和電解質分析儀
    • 凝血分析儀
    • 微生物系統
  • 耗材、試劑、試劑盒
    • 檢測套組
    • 試劑
    • 檢測試劑盒
    • 用於品管的產品和用於校準的樣品。
  • 軟體和診斷服務

第7章 全球伴侶動物診斷市場：依技術分類

  • 臨床生物化學
  • 免疫診斷
    • ELISA
    • 橫向流動化驗
    • 螢光免疫分析
  • 分子診斷
    • PCR
    • 即時PCR（qPCR）
    • 等溫擴增
    • 次世代定序（NGS）
  • 血液學
  • 尿液檢查
  • 微生物學
  • 細胞學和組織病理學
  • 臨床病理
  • 其他技術

第8章 全球伴侶動物診斷市場：依適應症分類

  • 感染疾病
  • 內分泌疾病
  • 心血管疾病
  • 消化系統疾病
  • 腎臟疾病
  • 肝病
  • 癌症和腫瘤學
  • 代謝性疾病
  • 遺傳性疾病
  • 過敏症與自體免疫疾病
  • 其他改編

第9章 全球伴侶動物診斷市場：依樣本類型分類

  • 血
  • 尿
  • 糞便檢體
  • 組織檢體
  • 唾液
  • 拭子檢體
  • 血清和血漿
  • 其他檢體類型

第10章：全球伴侶動物診斷市場：依檢測地點分類

  • 即時檢測
  • 參考實驗室
  • 內部獸醫檢查室
  • 學術和研究實驗室

第11章 全球伴侶動物診斷市場：以最終用戶分類

  • 獸醫醫院和診所
  • 獸醫診斷檢測實驗室
  • 學術研究機構
  • 動物收容所及救援中心
  • 居家醫療
  • 其他最終用戶

第12章 全球伴侶動物診斷市場：依應用領域分類

  • 定期健康檢查
  • 疾病診斷
  • 疾病監測
  • 預防性篩檢
  • 術前評估
  • 健康計劃
  • 其他用途

第13章：全球伴侶動物診斷市場：依通路分類

  • 直銷
  • 獸藥批發商
  • 線上銷售
  • 零售藥房
  • 其他分銷管道

第14章 全球伴侶動物診斷市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第15章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第16章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品上市及法規核准
  • 擴大生產能力和投資
  • 其他策略舉措

第17章：公司簡介

  • IDEXX Laboratories, Inc.
  • Zoetis Inc.
  • Heska Corporation
  • Virbac SA
  • Thermo Fisher Scientific Inc.
  • Agrolabo SpA
  • INDICAL BIOSCIENCE GmbH
  • FUJIFILM Corporation
  • bioMerieux SA
  • Randox Laboratories Ltd.
  • Neogen Corporation
  • BioNote Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Eurofins Scientific SE
  • Antech Diagnostics（Mars Inc.）
  • Esaote SpA
  • Scil Animal Care Company GmbH
  • Carestream Health Inc.
Product Code: SMRC38671

According to Stratistics MRC, the Global Companion Animal Diagnostics Market is accounted for $3.0 billion in 2026 and is expected to reach $6.4 billion by 2034 growing at a CAGR of 9.9% during the forecast period. Companion animal diagnostics encompasses products and services used for the detection, diagnosis, and monitoring of diseases and health conditions in companion animals including dogs, cats, horses, birds, rabbits, and other companion animals. The market includes diagnostic instruments such as hematology analyzers, clinical chemistry analyzers, immunodiagnostic analyzers, molecular diagnostic instruments, urinalysis analyzers, blood gas and electrolyte analyzers, coagulation analyzers, and microbiology systems, along with consumables, reagents, kits, and software and diagnostic services. Growing pet ownership, increasing demand for advanced veterinary care, rising prevalence of chronic diseases in companion animals, and technological advancements in diagnostic technologies are key drivers of market expansion across all regions.

Market Dynamics:

Driver:

Increasing pet ownership and demand for advanced veterinary care

The rising global pet population and growing demand for sophisticated veterinary medical care are primary drivers for the companion animal diagnostics market. Pet owners increasingly consider their animals as family members and are willing to invest in advanced diagnostic procedures comparable to human healthcare. The humanization of pets has led to greater expectations for accurate diagnosis, disease monitoring, and preventive care. As veterinary practices expand services and specialty care becomes more accessible, diagnostic testing utilization increases. Growing awareness of the benefits of early disease detection through diagnostic testing further supports market growth. These trends across developed and emerging markets sustain strong demand for companion animal diagnostic solutions.

Restraint:

High costs of diagnostic instruments and limited practice budgets

The significant capital investment required for diagnostic instruments and limited veterinary practice budgets represent a major restraint for the market. Advanced diagnostic instruments including hematology analyzers, molecular diagnostic systems, and immunodiagnostic platforms require substantial upfront investment. Smaller veterinary practices may lack sufficient capital for equipment acquisition. Ongoing consumables, reagents, maintenance, and service costs add to ownership expenses. Reimbursement limitations for veterinary diagnostics in many regions affect practice economics. These cost barriers may limit equipment adoption, particularly among smaller practices and in developing regions with constrained veterinary budgets.

Opportunity:

Technological advancements in point-of-care diagnostics

Continuous innovation in point-of-care diagnostic technologies presents significant opportunities for companion animal diagnostics market expansion. Portable and handheld diagnostic devices enable rapid, on-site testing, improving clinical decision-making and patient outcomes. Advances in molecular diagnostics including PCR and isothermal amplification enable infectious disease detection at the point of care. Immunoassay technologies are becoming more accessible for in-clinic use. Digital diagnostic platforms with connectivity features enable remote consultation and data sharing. As point-of-care technologies become more affordable and accessible, diagnostic testing expands to more practices, capturing growing market share and improving patient care.

Threat:

Shortage of veterinary specialists and training requirements

The limited availability of veterinary specialists and the training requirements for diagnostic equipment operation pose significant threats to the market. Proper operation and interpretation of advanced diagnostic instruments require specialized training that may not be available in all practices. Staff training for instrument operation, maintenance, and quality control adds to operational costs. Veterinary practices may struggle to recruit qualified personnel to operate and interpret diagnostic systems. The shortage of specialists limits access to advanced diagnostic testing, particularly in underserved areas. These workforce challenges may slow equipment adoption and testing utilization, especially for advanced diagnostic modalities.

Covid-19 Impact:

The COVID-19 pandemic had a significant impact on the companion animal diagnostics market. Initial disruptions included reduced veterinary visits during lockdowns, supply chain interruptions, and practice closures. However, pet adoption surged during the pandemic, expanding the pet population and creating new patients. Telemedicine and remote consultation expanded, increasing demand for diagnostic data sharing. Veterinary practices adapted with enhanced infection control and contactless workflows. The pandemic heightened focus on preventive healthcare and early disease detection. Post-pandemic, elevated pet ownership and continued focus on pet health have sustained demand for diagnostic testing, with practices continuing investment in diagnostic capabilities.

The Dogs segment is expected to be the largest during the forecast period

The Dogs segment is expected to account for the largest market share during the forecast period, driven by the large and growing dog population, high veterinary visit frequency, and extensive diagnostic testing utilization. Dogs are the most common companion animals globally, with ownership rates exceeding other pet types across most regions. Dog owners demonstrate high spending on veterinary care and preventive health services. The segment benefits from extensive diagnostic protocols and established testing panels across disease categories. Growing awareness of canine health issues, expanding preventive care adoption, and increasing chronic disease prevalence drive testing demand. With the largest patient population and highest testing utilization, dogs maintain the largest market share.

The Molecular Diagnostic Instruments segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Molecular Diagnostic Instruments segment is predicted to witness the highest growth rate, fueled by increasing adoption of PCR and other molecular testing in veterinary practice, growing demand for infectious disease detection, and technological advancements making molecular diagnostics more accessible. Molecular diagnostic instruments enable detection of pathogens at the genetic level, providing high sensitivity and specificity for infectious disease diagnosis. The segment benefits from the expansion of veterinary infectious disease testing, including respiratory, gastrointestinal, and vector-borne diseases. Point-of-care molecular systems are increasing accessibility. As molecular testing becomes more routine in veterinary practice, this segment delivers the fastest market growth.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by high pet ownership rates, strong spending on veterinary care, and advanced veterinary healthcare infrastructure. The United States leads regional market growth with substantial investment in veterinary practices and diagnostic capabilities. High awareness of advanced diagnostic options among pet owners supports testing demand. Established veterinary specialist networks and referral practices create consistent diagnostic volumes. Strong presence of diagnostic equipment manufacturers and technology innovation drives adoption. With high pet spending and advanced veterinary infrastructure, North America maintains its dominant market position.

Region with highest CAGR:

Over the forecast period, the Asia-Pacific region is anticipated to exhibit the highest CAGR, driven by rising pet ownership, increasing disposable incomes, and growing awareness of advanced veterinary diagnostics across countries including China, India, Australia, and Southeast Asia. The region's rapidly growing pet population and expanding middle class create substantial demand for veterinary diagnostic services. Veterinary practice modernization and technology adoption are accelerating. Increasing investment in veterinary education and specialist training is expanding the talent pool. Growing awareness of diagnostic benefits and increasing insurance coverage support market expansion. As veterinary healthcare develops, Asia Pacific delivers the fastest companion animal diagnostics market growth globally.

Key players in the market

Some of the key players in Companion Animal Diagnostics Market include IDEXX Laboratories, Inc., Zoetis Inc., Heska Corporation, Virbac S.A., Thermo Fisher Scientific Inc., Agrolabo S.p.A., INDICAL BIOSCIENCE GmbH, FUJIFILM Corporation, bioMerieux SA, Randox Laboratories Ltd., Neogen Corporation, BioNote Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Eurofins Scientific SE, Antech Diagnostics (Mars Inc.), Esaote S.p.A., Scil Animal Care Company GmbH, and Carestream Health Inc.

Key Developments:

In April 2026, Zoetis expanded the diagnostic capabilities of its AI-powered point-of-care hematology analyzer, Vetscan OptiCell(TM), introducing Cellular Hemoglobin Concentration Mean (CHCM) and plateletcrit (PCT) parameters directly to in-clinic workflows.

In March 2026, Neogen announced the strategic divestiture of its global Animal Genomics business unit to Zoetis, redirecting its operational focus toward core food safety, environmental monitoring, and diagnostic test kits.

In January 2026, Antech announced the commercial launch of RapidRead(TM) Dental for Feline-an AI-powered radiology interpretation tool designed specifically for feline tooth resorption-and added in-house quantitative SDMA kidney function testing to its Element i+ diagnostic platform.

Animal Types Covered:

  • Dogs
  • Cats
  • Horses
  • Birds
  • Rabbits
  • Other Companion Animals

Products Covered:

  • Instruments
  • Consumables, Reagents and Kits
  • Software and Diagnostic Services

Technologies Covered:

  • Clinical Biochemistry
  • Immunodiagnostics
  • Molecular Diagnostics
  • Hematology
  • Urinalysis
  • Microbiology
  • Cytology and Histopathology
  • Clinical Pathology
  • Other Technologies

Indications Covered:

  • Infectious Diseases
  • Endocrine Disorders
  • Cardiovascular Disorders
  • Gastrointestinal Disorders
  • Renal Disorders
  • Hepatic Disorders
  • Cancer and Oncology
  • Metabolic Disorders
  • Genetic Disorders
  • Allergies and Autoimmune Diseases
  • Other Indications

Sample Types Covered:

  • Blood
  • Urine
  • Fecal Samples
  • Tissue Samples
  • Saliva
  • Swab Samples
  • Serum and Plasma
  • Other Sample Types

Testing Locations Covered:

  • Point-of-Care Testing
  • Reference Laboratories
  • In-House Veterinary Laboratories
  • Academic and Research Laboratories

End Users Covered:

  • Veterinary Hospitals and Clinics
  • Veterinary Diagnostic Laboratories
  • Academic and Research Institutes
  • Animal Shelters and Rescue Centers
  • Home Care Settings
  • Other End Users

Applications Covered:

  • Routine Health Screening
  • Disease Diagnosis
  • Disease Monitoring
  • Preventive Healthcare Screening
  • Pre-Surgical Assessment
  • Wellness Programs
  • Other Applications

Distribution Channels Covered:

  • Direct Sales
  • Veterinary Distributors
  • Online Sales
  • Retail Pharmacies
  • Other Distribution Channels

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Companion Animal Diagnostics Market, By Animal Type

  • 5.1 Dogs
  • 5.2 Cats
  • 5.3 Horses
  • 5.4 Birds
  • 5.5 Rabbits
  • 5.6 Other Companion Animals

6 Global Companion Animal Diagnostics Market, By Product

  • 6.1 Instruments
    • 6.1.1 Hematology Analyzers
    • 6.1.2 Clinical Chemistry Analyzers
    • 6.1.3 Immunodiagnostic Analyzers
    • 6.1.4 Molecular Diagnostic Instruments
    • 6.1.5 Urinalysis Analyzers
    • 6.1.6 Blood Gas and Electrolyte Analyzers
    • 6.1.7 Coagulation Analyzers
    • 6.1.8 Microbiology Systems
  • 6.2 Consumables, Reagents and Kits
    • 6.2.1 Test Kits
    • 6.2.2 Reagents
    • 6.2.3 Assay Kits
    • 6.2.4 Quality Controls and Calibrators
  • 6.3 Software and Diagnostic Services

7 Global Companion Animal Diagnostics Market, By Technology

  • 7.1 Clinical Biochemistry
  • 7.2 Immunodiagnostics
    • 7.2.1 ELISA
    • 7.2.2 Lateral Flow Assays
    • 7.2.3 Fluorescence Immunoassays
  • 7.3 Molecular Diagnostics
    • 7.3.1 PCR
    • 7.3.2 Real-Time PCR (qPCR)
    • 7.3.3 Isothermal Amplification
    • 7.3.4 Next-Generation Sequencing (NGS)
  • 7.4 Hematology
  • 7.5 Urinalysis
  • 7.6 Microbiology
  • 7.7 Cytology and Histopathology
  • 7.8 Clinical Pathology
  • 7.9 Other Technologies

8 Global Companion Animal Diagnostics Market, By Indication

  • 8.1 Infectious Diseases
  • 8.2 Endocrine Disorders
  • 8.3 Cardiovascular Disorders
  • 8.4 Gastrointestinal Disorders
  • 8.5 Renal Disorders
  • 8.6 Hepatic Disorders
  • 8.7 Cancer and Oncology
  • 8.8 Metabolic Disorders
  • 8.9 Genetic Disorders
  • 8.10 Allergies and Autoimmune Diseases
  • 8.11 Other Indications

9 Global Companion Animal Diagnostics Market, By Sample Type

  • 9.1 Blood
  • 9.2 Urine
  • 9.3 Fecal Samples
  • 9.4 Tissue Samples
  • 9.5 Saliva
  • 9.6 Swab Samples
  • 9.7 Serum and Plasma
  • 9.8 Other Sample Types

10 Global Companion Animal Diagnostics Market, By Testing Location

  • 10.1 Point-of-Care Testing
  • 10.2 Reference Laboratories
  • 10.3 In-House Veterinary Laboratories
  • 10.4 Academic and Research Laboratories

11 Global Companion Animal Diagnostics Market, By End User

  • 11.1 Veterinary Hospitals and Clinics
  • 11.2 Veterinary Diagnostic Laboratories
  • 11.3 Academic and Research Institutes
  • 11.4 Animal Shelters and Rescue Centers
  • 11.5 Home Care Settings
  • 11.6 Other End Users

12 Global Companion Animal Diagnostics Market, By Application

  • 12.1 Routine Health Screening
  • 12.2 Disease Diagnosis
  • 12.3 Disease Monitoring
  • 12.4 Preventive Healthcare Screening
  • 12.5 Pre-Surgical Assessment
  • 12.6 Wellness Programs
  • 12.7 Other Applications

13 Global Companion Animal Diagnostics Market, By Distribution Channel

  • 13.1 Direct Sales
  • 13.2 Veterinary Distributors
  • 13.3 Online Sales
  • 13.4 Retail Pharmacies
  • 13.5 Other Distribution Channels

14 Global Companion Animal Diagnostics Market, By Geography

  • 14.1 North America
    • 14.1.1 United States
    • 14.1.2 Canada
    • 14.1.3 Mexico
  • 14.2 Europe
    • 14.2.1 United Kingdom
    • 14.2.2 Germany
    • 14.2.3 France
    • 14.2.4 Italy
    • 14.2.5 Spain
    • 14.2.6 Netherlands
    • 14.2.7 Belgium
    • 14.2.8 Sweden
    • 14.2.9 Switzerland
    • 14.2.10 Poland
    • 14.2.11 Rest of Europe
  • 14.3 Asia Pacific
    • 14.3.1 China
    • 14.3.2 Japan
    • 14.3.3 India
    • 14.3.4 South Korea
    • 14.3.5 Australia
    • 14.3.6 Indonesia
    • 14.3.7 Thailand
    • 14.3.8 Malaysia
    • 14.3.9 Singapore
    • 14.3.10 Vietnam
    • 14.3.11 Rest of Asia Pacific
  • 14.4 South America
    • 14.4.1 Brazil
    • 14.4.2 Argentina
    • 14.4.3 Colombia
    • 14.4.4 Chile
    • 14.4.5 Peru
    • 14.4.6 Rest of South America
  • 14.5 Rest of the World (RoW)
    • 14.5.1 Middle East
      • 14.5.1.1 Saudi Arabia
      • 14.5.1.2 United Arab Emirates
      • 14.5.1.3 Qatar
      • 14.5.1.4 Israel
      • 14.5.1.5 Rest of Middle East
    • 14.5.2 Africa
      • 14.5.2.1 South Africa
      • 14.5.2.2 Egypt
      • 14.5.2.3 Morocco
      • 14.5.2.4 Rest of Africa

15 Strategic Market Intelligence

  • 15.1 Industry Value Network and Supply Chain Assessment
  • 15.2 White-Space and Opportunity Mapping
  • 15.3 Product Evolution and Market Life Cycle Analysis
  • 15.4 Channel, Distributor, and Go-to-Market Assessment

16 Industry Developments and Strategic Initiatives

  • 16.1 Mergers and Acquisitions
  • 16.2 Partnerships, Alliances, and Joint Ventures
  • 16.3 New Product Launches and Regulatory Approvals
  • 16.4 Capacity Expansion and Investments
  • 16.5 Other Strategic Initiatives

17 Company Profiles

  • 17.1 IDEXX Laboratories, Inc.
  • 17.2 Zoetis Inc.
  • 17.3 Heska Corporation
  • 17.4 Virbac S.A.
  • 17.5 Thermo Fisher Scientific Inc.
  • 17.6 Agrolabo S.p.A.
  • 17.7 INDICAL BIOSCIENCE GmbH
  • 17.8 FUJIFILM Corporation
  • 17.9 bioMerieux SA
  • 17.10 Randox Laboratories Ltd.
  • 17.11 Neogen Corporation
  • 17.12 BioNote Inc.
  • 17.13 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 17.14 Eurofins Scientific SE
  • 17.15 Antech Diagnostics (Mars Inc.)
  • 17.16 Esaote S.p.A.
  • 17.17 Scil Animal Care Company GmbH
  • 17.18 Carestream Health Inc.

List of Tables

  • 1 Global Companion Animal Diagnostics Market Outlook, By Region (2023-2034) ($MN)
  • 2 Global Companion Animal Diagnostics Market Outlook, By Animal Type (2023-2034) ($MN)
  • 3 Global Companion Animal Diagnostics Market Outlook, By Dogs (2023-2034) ($MN)
  • 4 Global Companion Animal Diagnostics Market Outlook, By Cats (2023-2034) ($MN)
  • 5 Global Companion Animal Diagnostics Market Outlook, By Horses (2023-2034) ($MN)
  • 6 Global Companion Animal Diagnostics Market Outlook, By Birds (2023-2034) ($MN)
  • 7 Global Companion Animal Diagnostics Market Outlook, By Rabbits (2023-2034) ($MN)
  • 8 Global Companion Animal Diagnostics Market Outlook, By Other Companion Animals (2023-2034) ($MN)
  • 9 Global Companion Animal Diagnostics Market Outlook, By Product (2023-2034) ($MN)
  • 10 Global Companion Animal Diagnostics Market Outlook, By Instruments (2023-2034) ($MN)
  • 11 Global Companion Animal Diagnostics Market Outlook, By Hematology Analyzers (2023-2034) ($MN)
  • 12 Global Companion Animal Diagnostics Market Outlook, By Clinical Chemistry Analyzers (2023-2034) ($MN)
  • 13 Global Companion Animal Diagnostics Market Outlook, By Immunodiagnostic Analyzers (2023-2034) ($MN)
  • 14 Global Companion Animal Diagnostics Market Outlook, By Molecular Diagnostic Instruments (2023-2034) ($MN)
  • 15 Global Companion Animal Diagnostics Market Outlook, By Urinalysis Analyzers (2023-2034) ($MN)
  • 16 Global Companion Animal Diagnostics Market Outlook, By Blood Gas and Electrolyte Analyzers (2023-2034) ($MN)
  • 17 Global Companion Animal Diagnostics Market Outlook, By Coagulation Analyzers (2023-2034) ($MN)
  • 18 Global Companion Animal Diagnostics Market Outlook, By Microbiology Systems (2023-2034) ($MN)
  • 19 Global Companion Animal Diagnostics Market Outlook, By Consumables, Reagents and Kits (2023-2034) ($MN)
  • 20 Global Companion Animal Diagnostics Market Outlook, By Test Kits (2023-2034) ($MN)
  • 21 Global Companion Animal Diagnostics Market Outlook, By Reagents (2023-2034) ($MN)
  • 22 Global Companion Animal Diagnostics Market Outlook, By Assay Kits (2023-2034) ($MN)
  • 23 Global Companion Animal Diagnostics Market Outlook, By Quality Controls and Calibrators (2023-2034) ($MN)
  • 24 Global Companion Animal Diagnostics Market Outlook, By Software and Diagnostic Services (2023-2034) ($MN)
  • 25 Global Companion Animal Diagnostics Market Outlook, By Technology (2023-2034) ($MN)
  • 26 Global Companion Animal Diagnostics Market Outlook, By Clinical Biochemistry (2023-2034) ($MN)
  • 27 Global Companion Animal Diagnostics Market Outlook, By Immunodiagnostics (2023-2034) ($MN)
  • 28 Global Companion Animal Diagnostics Market Outlook, By ELISA (2023-2034) ($MN)
  • 29 Global Companion Animal Diagnostics Market Outlook, By Lateral Flow Assays (2023-2034) ($MN)
  • 30 Global Companion Animal Diagnostics Market Outlook, By Fluorescence Immunoassays (2023-2034) ($MN)
  • 31 Global Companion Animal Diagnostics Market Outlook, By Molecular Diagnostics (2023-2034) ($MN)
  • 32 Global Companion Animal Diagnostics Market Outlook, By PCR (2023-2034) ($MN)
  • 33 Global Companion Animal Diagnostics Market Outlook, By Real-Time PCR (qPCR) (2023-2034) ($MN)
  • 34 Global Companion Animal Diagnostics Market Outlook, By Isothermal Amplification (2023-2034) ($MN)
  • 35 Global Companion Animal Diagnostics Market Outlook, By Next-Generation Sequencing (NGS) (2023-2034) ($MN)
  • 36 Global Companion Animal Diagnostics Market Outlook, By Hematology (2023-2034) ($MN)
  • 37 Global Companion Animal Diagnostics Market Outlook, By Urinalysis (2023-2034) ($MN)
  • 38 Global Companion Animal Diagnostics Market Outlook, By Microbiology (2023-2034) ($MN)
  • 39 Global Companion Animal Diagnostics Market Outlook, By Cytology and Histopathology (2023-2034) ($MN)
  • 40 Global Companion Animal Diagnostics Market Outlook, By Clinical Pathology (2023-2034) ($MN)
  • 41 Global Companion Animal Diagnostics Market Outlook, By Other Technologies (2023-2034) ($MN)
  • 42 Global Companion Animal Diagnostics Market Outlook, By Indication (2023-2034) ($MN)
  • 43 Global Companion Animal Diagnostics Market Outlook, By Infectious Diseases (2023-2034) ($MN)
  • 44 Global Companion Animal Diagnostics Market Outlook, By Endocrine Disorders (2023-2034) ($MN)
  • 45 Global Companion Animal Diagnostics Market Outlook, By Cardiovascular Disorders (2023-2034) ($MN)
  • 46 Global Companion Animal Diagnostics Market Outlook, By Gastrointestinal Disorders (2023-2034) ($MN)
  • 47 Global Companion Animal Diagnostics Market Outlook, By Renal Disorders (2023-2034) ($MN)
  • 48 Global Companion Animal Diagnostics Market Outlook, By Hepatic Disorders (2023-2034) ($MN)
  • 49 Global Companion Animal Diagnostics Market Outlook, By Cancer and Oncology (2023-2034) ($MN)
  • 50 Global Companion Animal Diagnostics Market Outlook, By Metabolic Disorders (2023-2034) ($MN)
  • 51 Global Companion Animal Diagnostics Market Outlook, By Genetic Disorders (2023-2034) ($MN)
  • 52 Global Companion Animal Diagnostics Market Outlook, By Allergies and Autoimmune Diseases (2023-2034) ($MN)
  • 53 Global Companion Animal Diagnostics Market Outlook, By Other Indications (2023-2034) ($MN)
  • 54 Global Companion Animal Diagnostics Market Outlook, By Sample Type (2023-2034) ($MN)
  • 55 Global Companion Animal Diagnostics Market Outlook, By Blood (2023-2034) ($MN)
  • 56 Global Companion Animal Diagnostics Market Outlook, By Urine (2023-2034) ($MN)
  • 57 Global Companion Animal Diagnostics Market Outlook, By Fecal Samples (2023-2034) ($MN)
  • 58 Global Companion Animal Diagnostics Market Outlook, By Tissue Samples (2023-2034) ($MN)
  • 59 Global Companion Animal Diagnostics Market Outlook, By Saliva (2023-2034) ($MN)
  • 60 Global Companion Animal Diagnostics Market Outlook, By Swab Samples (2023-2034) ($MN)
  • 61 Global Companion Animal Diagnostics Market Outlook, By Serum and Plasma (2023-2034) ($MN)
  • 62 Global Companion Animal Diagnostics Market Outlook, By Other Sample Types (2023-2034) ($MN)
  • 63 Global Companion Animal Diagnostics Market Outlook, By Testing Location (2023-2034) ($MN)
  • 64 Global Companion Animal Diagnostics Market Outlook, By Point-of-Care Testing (2023-2034) ($MN)
  • 65 Global Companion Animal Diagnostics Market Outlook, By Reference Laboratories (2023-2034) ($MN)
  • 66 Global Companion Animal Diagnostics Market Outlook, By In-House Veterinary Laboratories (2023-2034) ($MN)
  • 67 Global Companion Animal Diagnostics Market Outlook, By Academic and Research Laboratories (2023-2034) ($MN)
  • 68 Global Companion Animal Diagnostics Market Outlook, By End User (2023-2034) ($MN)
  • 69 Global Companion Animal Diagnostics Market Outlook, By Veterinary Hospitals and Clinics (2023-2034) ($MN)
  • 70 Global Companion Animal Diagnostics Market Outlook, By Veterinary Diagnostic Laboratories (2023-2034) ($MN)
  • 71 Global Companion Animal Diagnostics Market Outlook, By Academic and Research Institutes (2023-2034) ($MN)
  • 72 Global Companion Animal Diagnostics Market Outlook, By Animal Shelters and Rescue Centers (2023-2034) ($MN)
  • 73 Global Companion Animal Diagnostics Market Outlook, By Home Care Settings (2023-2034) ($MN)
  • 74 Global Companion Animal Diagnostics Market Outlook, By Other End Users (2023-2034) ($MN)
  • 75 Global Companion Animal Diagnostics Market Outlook, By Application (2023-2034) ($MN)
  • 76 Global Companion Animal Diagnostics Market Outlook, By Routine Health Screening (2023-2034) ($MN)
  • 77 Global Companion Animal Diagnostics Market Outlook, By Disease Diagnosis (2023-2034) ($MN)
  • 78 Global Companion Animal Diagnostics Market Outlook, By Disease Monitoring (2023-2034) ($MN)
  • 79 Global Companion Animal Diagnostics Market Outlook, By Preventive Healthcare Screening (2023-2034) ($MN)
  • 80 Global Companion Animal Diagnostics Market Outlook, By Pre-Surgical Assessment (2023-2034) ($MN)
  • 81 Global Companion Animal Diagnostics Market Outlook, By Wellness Programs (2023-2034) ($MN)
  • 82 Global Companion Animal Diagnostics Market Outlook, By Other Applications (2023-2034) ($MN)
  • 83 Global Companion Animal Diagnostics Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • 84 Global Companion Animal Diagnostics Market Outlook, By Direct Sales (2023-2034) ($MN)
  • 85 Global Companion Animal Diagnostics Market Outlook, By Veterinary Distributors (2023-2034) ($MN)
  • 86 Global Companion Animal Diagnostics Market Outlook, By Online Sales (2023-2034) ($MN)
  • 87 Global Companion Animal Diagnostics Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • 88 Global Companion Animal Diagnostics Market Outlook, By Other Distribution Channels (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.